Chapter 273 (2/2)
”Hello, Professor He. I've heard a lot about you.”
”Ha ha, if you want to say I've heard so much, it should be the name of Zhou Suo, which is just like Lei Guaner...”
”You sit, you sit down ~” after two people exchanged greetings, Zhou Wen reached out and motioned he Junfeng to sit down.
After sitting down, he Junfeng first congratulated Zhou Wen for winning the geldena international award, and then naturally led the topic to Zhou Wen's paper the role of ion channels as HBV drug targets.He Junfeng asked some questions.
Zhou Wen knows that he Junfeng is the authority of hepatitis B in China. He must have seen something from that paper, so he told him directly without concealing some things.
Anyway, the target of the drug is not too much, even if you tell him it doesn't matter.
But he didn't say a word about the core things. It was not that he didn't trust him. The main thing was that some things related to patents, which would be very troublesome if they were leaked out.
He Junfeng and Zhou Wen talked for more than an hour and got some answers.
However, Zhou Wen didn't say a word about the key issue, which made him feel like being scratched by a cat's paw.
It felt like the pants were taken off, and a prompt box popped up. The following contents should not be the same for children
He wanted Zhou Wenduo to talk more about it, but he also knew that some things related to company secrets, so it was impossible for someone else to tell him.
What to do?
He Junfeng scratched his ears and scratched his cheek, ”Zhou Suo, can you talk more about it?”
Zhou Wen shook his head and said with a smile, ”I'm sorry, Professor He. I don't know the next direction. Further experiments are needed.”
”Excuse.”
”All excuses!”
Looking at the smiling expression on Zhou Wen's face, he Junfeng is angry in his heart, but he can't help it.
”How can you tell me?” he asked
”I don't know about that!” Zhou Wen showed helplessness, and then followed: ”that Our laboratory is preparing to set up a team to tackle the problem of HBV drugs. We are short of a valuable expert consultant I wonder if professor he is willing to take up the post? ”
When you hear the sound of a string, you will know its elegance.
He Junfeng heard it and immediately recalled it.
If he becomes an expert consultant of Huanqiu biology, he must sign a competition agreement, so that Zhou Wen doesn't have to worry about the leakage of secrets, and he can know more.
Thinking of this, he Junfeng immediately said: ”OK, no problem.”
As soon as he Junfeng's voice dropped, the experimental assistant sitting next to Zhou Wen immediately went to his desk to get an employment contract.
”Professor He, here you are.”
He Junfeng Leng for a moment, and then can't laugh and cry, feeling people have been waiting for themselves.
But I took over the contract.
Experimental assistant xiaohehe handed over the pen, and then informed he Junfeng of the signing position.
He Junfeng also did not look at the contract content, I believe that Zhou Wen still dare not sign him a overlord agreement.
After signing the employment contract, the laboratory assistant immediately handed in a confidentiality agreement.
He Junfeng:
Sure enough.
What else can I do if I'm on a pirate ship? Of course, I signed.
After signing the confidentiality agreement, he Junfeng couldn't wait to ask, ”can you say it now?”
Zhou Wen looked at his assistant.
The assistant immediately got up and went to the office immediately.
Zhou Wen answers he Junfeng's questions with a smile
When he Junfeng left, his face was full of excitement and excitement.
Originally I thought that we could not see HBV completely cured in our lifetime, but now it seems that there is a great hope that we may see the dawn in three or five years.
……
After he Junfeng left here, Zhou Wensui entered the laboratory with him.
From the first year to the first time, all compounds need to be screened and evaluated from the first year to clinical trials.
Then clinical trials, even in the United States, will take at least three years if everything goes well.
And the pre Market Assessment
So it's a long way to go.
This is the ”three tens” law in drug research and development.
It takes 10 years, 1 billion US dollars, and the success rate of R & D is less than 10%.
Moreover, according to the latest report released by Deloitte, the cost of successfully launching a new drug has increased from $1.188 billion in 2010 to $1.981 billion in 2019.
The law of three tens may no longer be applicable, and the future situation will be more severe.
Of course, it doesn't include cosmopolitan creatures
, the fastest update of the webnovel!